左侧乳腺癌深吸气屏气下内乳链放疗的心脏保护特征
研究回顾2012至2015年168例接受深吸气屏气辅助左侧放疗的患者,其中49例接受淋巴结照射(16例锁骨上野加内乳,33例仅锁骨上野)。深吸气屏气使内乳组心脏平均剂量从6.73 Gy降至2.79 Gy(-56.4%),未内乳组从4.77 Gy降至1.55 Gy(-63.7%);内乳照射仍与更高的心脏剂量相关,估计主要冠脉事件风险比例增加9.2%。
要点
- 深吸气屏气在内乳照射时仍显著降低心脏平均剂量(p<0.001)。
- 内乳组心脏平均剂量6.73 Gy降至2.79 Gy(-56.4%),未内乳组4.77 Gy降至1.55 Gy(-63.7%)。
- 内乳照射与更高的心脏剂量 intrinsically 相关,估计主要冠脉事件风险比例增加9.2%。
核心结论
- 深吸气屏气技术的相对心脏保护获益在内乳链纳入照射时仍然保留,但内乳照射与更高的心脏剂量 intrinsically 相关,估计主要冠脉事件风险比例增加9.2%。
- 在有效心脏保护技术条件下,临床医生应将这些考虑纳入内乳治疗指征的决策。
研究设计与样本
- 回顾性分析2012至2015年168例接受深吸气屏气辅助左侧乳腺癌放疗的连续患者,其中49例接受淋巴结照射:16例锁骨上野加内乳,33例仅锁骨上野。
- 从自由呼吸和深吸气屏气治疗计划计算心脏平均剂量和剂量体积,采用Wilcoxon符号秩检验和Mann-Whitney U检验比较。
主要发现
- 深吸气屏气使内乳治疗组心脏平均剂量从6.73 Gy降至2.79 Gy(-56.4%),未内乳组从4.77 Gy降至1.55 Gy(-63.7%),两组均p<0.001。
- 两组相对降低幅度差异为7.3%,无统计学显著性(p=0.216)。
- 内乳照射患者的心脏剂量体积相对降低均显著更低(p≤0.012),V5处差异最大,随剂量增加(V25)逐渐减小。
关键数值与推荐
- 内乳治疗组心脏平均剂量:自由呼吸6.73 Gy vs 深吸气屏气2.79 Gy(降低56.4%)。
- 未内乳组心脏平均剂量:自由呼吸4.77 Gy vs 深吸气屏气1.55 Gy(降低63.7%)。
- 两组相对降低幅度差异7.3%(p=0.216)。
- 内乳照射与主要冠脉事件风险比例增加9.2%相关(估计值)。
临床怎么用
- 原文结论指出,在有效心脏保护技术条件下,临床医生应将这些考虑纳入内乳治疗指征的决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While breast radiotherapy typically includes regional nodal basins, the treatment of the internal mammary nodes (IMN) has been controversial due to concern for long-term cardiac toxicity. For high risk patients where IMN treatment is warranted, there is limited data with regards to the degree of heart sparing conferred by modern techniques. In this study, we sought to analyze the specific heart sparing metrics conferred by deep inspiration breath hold (DIBH) in the setting of IMN irradiation. METHODS: From 2012 to 2015, 168 consecutive patients were treated with adjuvant left-sided radiotherapy using DIBH. Retrospective review identified 49 patients who received nodal irradiation, either to a supraclavicular field (SCF) and IMN (16), or to the SCF alone (33). Cardiac mean dose and dose volumes were calculated from free breathing (FB) and DIBH treatment plans, and compared by Wilcoxon signed-rank and Mann-Whitney U tests. RESULTS: DIBH achieved significant reductions in mean heart dose (p < 0.001) in both the IMN treated group from 6.73 Gy to 2.79 Gy (- 56.4%) and the IMN untreated group from 4.77 Gy to 1.55 Gy (- 63.7%). There was a 7.3% difference in relative reduction that was not statistically significant (p = 0.216). Relative reductions in heart dose volume measures were all significantly lower for IMN-irradiated patients (p ≤ 0.012), with the greatest deficits at V5 that gradually diminish with increasing dose (V25). CONCLUSIONS: The relative heart sparing benefits of the DIBH technique are retained even with IMN inclusion. However, the addition of IMN irradiation is associated with an intrinsically greater heart dose, which translates to an estimated 9.2% proportional increase in the risk of a subsequent major coronary event. In the setting of effective cardiac sparing techniques, clinicians should take these considerations into account to guide when IMN treatment is warranted.
引用
- Nguyen MH, Lavilla M, Kim JN, et al. Cardiac sparing characteristics of internal mammary chain radiotherapy using deep inspiration breath hold for left-sided breast cancer. Radiat Oncol. 2018. PMID: 29855325. doi:10.1186/s13014-018-1052-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。